Azzad Asset Management Inc /Adv Harmony Biosciences Holdings, Inc. Transaction History

Azzad Asset Management Inc /Adv

  • $891 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 01, 2024
SELL
$19.2 - $33.78 $165,254 - $290,744
-8,607 Closed
0 $0
Q3 2023

Apr 01, 2024
BUY
$31.89 - $39.03 $6,728 - $8,235
211 Added 2.51%
8,607 $282 Million
Q2 2023

Apr 01, 2024
BUY
$30.5 - $37.4 $5,307 - $6,507
174 Added 2.12%
8,396 $295 Million
Q1 2023

Apr 01, 2024
BUY
$30.8 - $53.92 $253,237 - $443,330
8,222 New
8,222 $268 Million

Others Institutions Holding HRMY

# of Institutions
242
Shares Held
45.1M
Call Options Held
108K
Put Options Held
49.2K
View Full List

About Harmony Biosciences Holdings, Inc.

HRMY Quotes by TradingView
  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $2.05B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email